What is the key question? Does the development of a postoperative pulmonary 22 complication (PPC) following thoracic surgery for lung resection impact on long-term 23
survival? 24
What is the bottom line? After excluding immediate post-operative deaths, 25 developing a PPC is a significant independent risk factor for late deaths and these 26 patients have a worse long-term survival. 27
Why read on? We demonstrate in our large prospective cohort that PPCs are 28 common following thoracic surgery, both the short and long-term effects of 29 developing a PPC are striking; COPD and smoking are significant independent risk 30 factors. 31 32 ABSTRACT 33
Introduction Postoperative pulmonary complications (PPC) such as atelectasis and 34 pneumonia are common following lung resection. PPCs have a significant clinical 35 impact on postoperative morbidity and mortality. We studied the long-term effects 36 of PPCs and sought to identify independent risk factors. 37
Methods A prospective observational study involved all patients following lung 38 resection in a regional thoracic centre over 4 years. PPCs were assessed daily in 39 hospital using the Melbourne group scale based on chest x-ray, white cell count, 40 fever, purulent sputum, microbiology, oxygen saturations, physician diagnosis and 41 intensive therapy unit (ITU)/high dependency unit readmission. Follow up included 42 hospital length of stay (LOS), 30-day readmissions, and mortality. 43
Results 86 of 670 patients (13%) who underwent a lung resection developed a PPC. 44
Those patients had a significantly longer hospital LOS in days (13, 95%CI 10.5-14.9 vs. 45 6.3, 95%CI 5.9-6.7; p<0.001) and higher rates of both ITU admissions (28% vs. 1.9%; 46 p<0.001) and 30-day hospital readmissions (20.7% vs. 11.9%; p<0.05). Significant 47 independent risk factors for development of PPC were COPD and smoking (p<0.05), 48 not age. Excluding early postoperative deaths, developing a PPC resulted a 49 significantly reduced overall survival in months (40 95%CI 34-44 vs. 46 95%CI 44-47; 50 p=0.006). Developing a PPC is associated with a higher non-cancer related late 51 deaths (11 vs. 5%; p=0.020). PPC is a significant independent risk factor for late 52 deaths in non-small cell lung cancer patients (HR 2.0, 95%CI 1.9-3.2; p=0.006). 53
Conclusion Developing a PPC after thoracic surgery is common and is associated 54 with a poorer long-term outcome. 55
BACKGROUND 57
Lung cancer is the most common cause of cancer death within the UK [1] . For 2007 EUROCARE-5 report [7] . A more recent study has shown that cancer survival in 68
England is improving, however continued investment is needed to close this 69 international gap [8] . Furthermore, whilst in hospital mortality has fallen over the 70 last 3 decades, mortality rates within the first 90 days of surgery are considerable 71
[9]. We need to understand the causes of these late complications if we are to 72 improve long-term outcomes. 73
Lung cancer resection is also associated with a considerable risk of postoperative 74 pulmonary complications (PPCs), of which pneumonia and atelectasis are the most 75 common [10]. PPCs have a significant health and economic impact on patients and 76 health care services. Indeed, as less fit patients are undergoing surgery, the 77 incidence of PPCs is likely to increase further. The longer-term effects of developing 78 a PPC in hospital following lung cancer surgery have not been defined. The 79 identification of modifiable risk factors for PPCs has a crucial role in the development 80 of innovative strategies to reduce the impact and incidence of PPCs. We hypothesise 81 that PPCs are associated with the late postoperative mortality and morbidity 82 observed following lung resection. 83
This study aims to assess both immediate and long-term impact of PPCs, and to 84 identify potentially modifiable independent risk factors. 85
86

METHODS 87
This prospective observational study was conducted at a single centre large regional 88 thoracic unit serving 6 million people. Consecutive patients who underwent open 89 thoracotomy or video-assisted thoracoscopic surgery (VATS) for lung 90 resection/removal in a regional thoracic centre between April 2010 and April 2014 91 were observed. This study was conducted with the approval of the National 92
Research Ethics Service (NRES) Committee West Midlands. This study was registered 93 with the Birmingham Heartlands Hospital audit department (audit code 1672). 94
Decisions regarding patient operability and resectability were informed by the British 95
Thoracic Society guidelines for lung cancer resection [6] . 96
Patients were admitted to hospital on the day of surgery. All operations were 97 performed with single lung ventilation under general anaesthesia, and patients were 98 The Melbourne Group Scale (MGS) is a standardised scoring system validated by our 109 group to define the presence of a PPC such as pneumonia or clinically significant 110 atelectasis, which are likely to adversely affect the patient's clinical course [10] [11] . 111
Using this score, PPC is defined in those patients presenting with four or more of the 112 following eight dichotomous factors: chest x-ray (CXR) findings of atelectasis or 113 consolidation; raised white cell count (WCC) (>11.2x10 9 /l); temperature >38°C; signs 114 of infection on sputum microbiology; purulent sputum differing from preoperative 115 status; oxygen saturations <90% on room air; physician diagnosis of pneumonia; and 116 prolonged HDU stay or readmission to HDU or ITU for respiratory complications. The 117 MGS was used daily by senior physiotherapists who were performing their routine 118 respiratory assessments. The discharge criteria, agreed with investigators in advance 119 included patients who were medically fit and who had been discharged from 120 physiotherapy. 
Statistical analysis 138
Results are expressed as mean (SD or 95% CI) for continuous variables and as a 139 percentage for categorical variables. Univariate analysis of risk factors for 140 development of PPC were assessed by performing individual un-adjusted logistic 141 regression analysis, inclusion of one covariate at a time. Risk ratios with 95%CI were 142 generated for variables found to have statistically significant association with PPC on 143 univariate analysis. A backward multivariate binary logistic regression analysis was 144 performed to identify the independent predictors of PPC within this dataset. 145
The effect of PPC on hospital, HDU and ITU LOS were assessed using the Mann-146
Whitney non-parametric test to accommodate for the presence of positive 147 skewness. Kaplan Meyer plots and the log-rank test were used to assess the impact 148 of PPC on survival. Cox regression was assessed including all risk factors in a model 149 for long-term survival. All analyses were performed using the IBM SPSS version 20 150 and SAS 9.3 statistical package version (SAS Institue, Inc, Carry NC). 151
152
RESULTS 153
There were 670 patients who underwent pulmonary resections during the study 154 period; 377 of who were male (56%). The mean±SD age of the group was 66.4±10.8 155 years. Mean predicted FEV 1 was 80.2±20.8%, mean BMI 26.9±8.1 kg/m 2 , 328 156 patients (49%) had an ASA score ≥3, 176 patients (26%) had COPD, 149 patients 157 (22%) were current smokers. 158
The most frequent procedure was lobectomy (n=497, 74%) followed by wedge or 159 segmentectomy (n=111, 16%) and pneumonectomy (n=37, 5.5%). VATS lobectomy 160 and segmentectomy were also performed (n=54, 8% and n=8, 1% respectively). 161
Most common histological diagnosis was NSCLC (n=477, 71.2%) followed by benign 162 disease (n=73, 11%) and metastatic disease of non-lung primary (n=69, 10.3%). 10.5-14.9 vs. 6.3, 95%CI 5.9-6.7; p<0.001), longer HDU LOS (4.2, 95%CI 3.4-4.9 vs. 1.9 207 95%CI 1.8-2.1, p<0.001) and longer ITU LOS (2.1, 95%CI 1.0-3.3 vs. 0.2, 95%CI 0.1-0.4, 208 p<0.001). In the PPC group there were higher rates of ITU admissions (28% vs. 1.9%; 209 p<0.001) ( figure 1, table 3 Our study has confirmed that PPCs are common in thoracic surgery. The short-term 238 morbidity of developing a PPC following thoracic surgery is striking, with significantly 239 longer hospital, ITU and HDU LOS, higher frequency of ITU admissions and higher 240 frequency of hospital readmissions secondary to pulmonary infections. Furthermore, 241 patients who develop a PPC have a significantly increased mortality, both in the early 242 and late stages following surgery. After excluding immediate post-operative deaths, 243 developing a PPC is a significant independent risk factor for late deaths and these 244 patients have a worse long-term survival. Furthermore we observed a high rate of 245 non-cancer related deaths in this cohort. 246
The frequency of PPCs observed at this regional thoracic surgery unit (13%) is 247 concurrent with other studies [10-15]. The incidence of PPC following thoracic 248 surgery ranges between studies predominantly because there is no standard; it is 249 dependent on the type of complications included, the definition of pulmonary 250 complications, and the type of surgery. Use of the objective MGS to define PPC does 251 not include rare but serious postoperative complications such as broncho-pleural 252 fistulas, which required re-operation in 0.4% of our patients, and also pulmonary 253 embolism, which has been described in 2% of patients after thoracic surgery [16] . 254
However, the fact that those more frequent, and probably less severe PPCs detected 255 by the MGS were still associated with a higher short and long-term mortality rate is 256 an important message. 257
Patients who develop a PPC are more than twice as likely to be readmitted within 258 30-days of surgery, and nearly 3 times more likely to re-present with respiratory 259 tract infections. Hospital readmission is not only a serious morbidity; we 260 demonstrate it also to be an independent risk factor for the late deaths observed in 261 our study. Patients who are readmitted within 30-days of lung cancer surgery have 262 been shown to have a 6-fold increase in 90-day postoperative mortality [17] . In our 263 study the 90-day mortality was 2.6 times that of 30-day mortality, compatible with 264 other study findings [9, 18]. Thus, this increased mortality following thoracic surgery 265 is not explained by immediate postoperative deaths alone; we hypothesised that 266
PPCs have a role in these later deaths observed. 267
Our study has shown that PPCs are significantly associated with reduced OS 268 following thoracic surgery for lung resection. There is a paucity of data on the 269 impact of PPCs on long-term outcome in thoracic surgery. A retrospective study 270 which included patients aged 66-80 who have undergone a lobectomy for stage 1 271 NSCLC found that development of a PPC was associated with reduced 5-year OS 272 (52.7 vs. 65.9%, p<0.001) and was an independent risk factor for mortality (HR 1.46, 273 95% CI, 1.24-1.73) [19] . We have also shown that developing a PPC is a independent 274 risk factor for late deaths, but in comparison our study is not limited by any inclusion 275 criteria other than national guidelines [6]. Therefore we have included those patients 276 who are older and have more advanced staging of cancer, which we and other 277 authors have found to be additional independent risk factors for late deaths [20, 21] . 278
We demonstrate for the first time that after excluding immediate postoperative 279 deaths, patients with a PPC are more likely to die of late non-cancer related deaths. 280
This compares to the outcome of patients who are admitted to hospital secondary to 281 community acquired pneumonia (CAP), these patients have an increased risk of 282 subsequent pneumonia and mortality after discharge, and a substantial proportion 283 of these deaths are due to non-malignant respiratory disease [22] . Some of the late 284 deaths in patients who developed a PPC were secondary to cardiovascular disease, 285 indeed there is increasing evidence that pneumonia is associated with increased risk 286 of cardiovascular complications, which may be due to residual inflammation having a 287 role in triggering procoagulant pathways in these individuals [23] . 288 COPD and current smoking were found to be independent risk factors in the 289 development of PPCs in ours and other studies [10, 21] . Our multivariate model for 290 assessing of risk factors has a c-index of 0.66 therefore it cannot be used as a 291 diagnostic/highly predictive tool as we would like a predictive power ideally more 292 than 80-90%. Nevertheless, our analysis identified factors having significant 293 association with PPC. Those patients diagnosed with COPD have increased risk of 294 both pneumonia and atelectasis after surgery [24, 25] . We found on univariate 295 analysis that a lower preoperative FEV 1 percentage predicted was associated with 296 the development of a PPC, though on multivariate analysis, FEV 1 is not an 297 independent risk factor, as previously shown [10] . In our study carbon monoxide 298 lung diffusion capacity (DLCO) was performed only in patients with limited exercise 299 tolerance or lung volumes so data are limited. However, studies have shown DLCO 300 not to be an independent risk factor for long-term survival following thoracic surgery 301 for lung cancer [26, 27] . Risk modification for patients with COPD would be through 302 a pulmonary rehabilitation programme [28] , which in thoracic surgery has shown 303 encouraging results in reducing PPCs [29] , but more robust studies are needed in this 304
field. 305
Smoking is the biggest independent risk factor for developing PPCs; indeed our study 306 has shown PPCs to be up to five times more common in current smokers when 307 compared to never smokers, similar to other study findings [30] . Key mechanisms 308 are likely to involve the effect smoking has on impairing the mucociliary escalator 309
[31], and also both the antimicrobial and pro-inflammatory functions of alveolar 310 macrophages, which decreases further during anaesthesia and surgery [32] . Risk 311 modification would be in the form of smoking cessation; however the duration 312 needed in order to reduce postoperative risk remains a debated topic and is a much-313 
Study strengths and limitations 324
This is a real-life study involving consecutive patients undergoing thoracic surgery in 325 a tertiary centre; our patient demographics and staging of cancer is comparable to 326 national data [9] . The main limitation of our study is the low number of VATS cases 327 recorded. VATS lobectomy has since increased to 1/3 of all lobectomies carried out 328 in the UK due to the perceived minimally invasive nature of the procedure with 329 reduced complications. Indeed we have previously described that the PPC incidence 330 in VATS cases seems to be lower [35] . The data of this study precedes the growth of 331 VATS lobectomies, therefore the majority of our lung resections over the time frame 332 were done via thoracotomy, within in the latter half of the study 2 of the 5 surgeons 333 had started to perform an increasing number of VATS lobectomies (35%), compared 334 to the first half of the study period (3.4%). The finding of VATS approach not to show 335 a significant reduction in incidence of PPC is most likely because of under powering. 336
Further studies into the effects of transition of thoracotomy to VATS on PPC 337 frequency and long-term outcome will need to be conducted. There is limitation 338 with regards to the patient follow up data; as information on mortality and cause of 339 death were obtained from hospital records and death certificates in a retrospective 340 manner, in a few patients cause of death could not be ascertained (5%). Additionally, 341
we did not follow up for cancer recurrence and therefore could not assess the effect 342 of PPC on disease free survival in patients with lung cancer, which would be an 343 interesting area for further investigation. 344
345
CONCLUSION 346
In summary, developing a PPC after thoracic surgery is associated with a poorer 347 long-term outcome. We have found COPD and smoking are independent risk factors 348 for developing PPCs, whilst age was not a predictive factor. Further research is 349 required into the effect of risk modification on the development of PPCs and 350 subsequent long-term outcome following thoracic surgery. 
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